Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
As of close of business last night, AnaptysBio Inc’s stock clocked out at $14.55, down -3.00% from its previous closing price of $15.00. In other words, the price has decreased by -$3.00 from its previous closing price. On the day, 1.59 million shares were traded. ANAB stock price reached its highest trading level at $15.29 during the session, while it also had its lowest trading level at $14.205.
Ratios:
To gain a deeper understanding of ANAB’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.23 and its Current Ratio is at 10.23. In the meantime, Its Debt-to-Equity ratio is 4.35 whereas as Long-Term Debt/Eq ratio is at 4.33.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, H.C. Wainwright on December 11, 2024, Downgraded its rating to Neutral and sets its target price to $19 from $52 previously.
On July 22, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $55.H.C. Wainwright initiated its Buy rating on July 22, 2024, with a $55 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 29 ’24 when RENTON HOLLINGS sold 10,000 shares for $25.00 per share. The transaction valued at 250,000 led to the insider holds 1,950 shares of the business.
HOLLINGS C RENTON bought 10,000 shares of ANAB for $250,000 on Nov 29 ’24. On Sep 23 ’24, another insider, Lizzul Paul F., who serves as the Chief Medical Officer of the company, sold 1,500 shares for $38.67 each. As a result, the insider received 58,005 and left with 15,398 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ANAB now has a Market Capitalization of 442737600 and an Enterprise Value of 379678336. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.51 while its Price-to-Book (P/B) ratio in mrq is 5.25. Its current Enterprise Value per Revenue stands at 6.641 whereas that against EBITDA is -2.723.
Stock Price History:
Over the past 52 weeks, ANAB has reached a high of $41.31, while it has fallen to a 52-week low of $14.20. The 50-Day Moving Average of the stock is -39.46%, while the 200-Day Moving Average is calculated to be -46.82%.
Shares Statistics:
It appears that ANAB traded 542.17K shares on average per day over the past three months and 1040920 shares per day over the past ten days. A total of 30.43M shares are outstanding, with a floating share count of 26.01M. Insiders hold about 14.52% of the company’s shares, while institutions hold 103.68% stake in the company. Shares short for ANAB as of 1732838400 were 7099413 with a Short Ratio of 13.09, compared to 1730332800 on 6175471. Therefore, it implies a Short% of Shares Outstanding of 7099413 and a Short% of Float of 31.86.
